Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q3 2024 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by, and welcome. [Operator Instructions] Please be advised that today’s conference call may be recorded.
Esperion Therapeutics Inc. (ESPR)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 33,750,000 | $32,018,625 | +3275% | 13.7% | |
| 2. | 25,000,000 | $23,703,125 | -17% | 0.64% | |
| 3. | 23,850,000 | $22,612,781 | 0.61% | ||
| 4. | 16,980,000 | $16,166,007 | 0.48% | ||
| 5. | Two Seas Capital Sina Toussi | 6,584,278 | $10,864,059 | +15% | 1.75% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.57 | 23,091 | Director | 36,500 | 2023-05-11 | Filing | |
| $1.49 | 8,409 | Director | 13,409 | 2023-05-10 | Filing | |
| $1.50 | 8,111 | Director | 8,111 | 2023-05-10 | Filing | |
| $1.26 | 20,000 | Officer, Director | 312,816 | 2023-05-09 | Filing | |
| $7.46 | 1,000 | Officer | 54,024 | 2022-08-31 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.42 | 3,245 | Officer | 240,691 | 2024-12-17 | Filing | |
| $2.43 | 2,234 | Officer | 160,121 | 2024-12-17 | Filing | |
| $2.47 | 12,447 | Officer, Director | 739,819 | 2024-12-17 | Filing | |
| $2.17 | 197 | Officer | 162,355 | 2024-11-19 | Filing | |
| $2.12 | 107 | Officer | 162,552 | 2024-10-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 41,029,000 | $32,542,716 | 10.6% | |
| 2. | 8,891,103 | $26,584,398 | 0.14% | |
| 3. | 5,137,750 | $15,361,873 | 0% | |
| 4. | 4,204,264 | $12,570,749 | 0.19% | |
| 5. | 3,791,300 | $11,335,987 | 14.16% |
News See All
7 Best NASDAQ Stocks Under $5
A Yahoo Finance report on September 28 reveals that consumers are beginning to feel the effects of a cooling labor market, according to the latest Consumer Confidence Index, which shows a narrowing gap...
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q2 2024 Earnings Call Transcript August 12, 2024Esperion Therapeutics, Inc. misses on earnings expectations.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q1 2024 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.00032, expectations were $-0.17.
11 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the 13 best low price pharma stocks to invest in.
5 Best Small Cap Pharma Stocks to Invest In
In this piece, we will take a look at the five best small cap pharma stocks to invest in.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc.
Esperion Therapeutics, Inc. (NASDAQ:ESPR) Q4 2023 Earnings Call Transcript
Esperion Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.5, expectations were $-0.53. Esperion Therapeutics, Inc.
12 Best Medical Stocks to Buy Under $10
In this article, we will take a look at the 12 best medical stocks to buy under $10.
Should You Sell Esperion Therapeutics (ESPR)?
Tourlite Capital Management, an investment management firm, released its fourth quarter 2023 investor letter, a copy of which can be downloaded here.
Billionaire Hedge Funds
